Top Healthcare Companies in USA List by Market Cap as on July-30-2023

Top Healthcare Companies in USA List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in USA Companies by Market Cap. Largest Top Healthcare Companies in USA List by Market Cap as on July-30-2023.
Top Healthcare Companies in USA
Top Healthcare Companies in USA, Biggest Healthcare Companies in USA, Largest Healthcare Companies in USA.

  1. Axogen

    World Rank (Jan-05-2024)
    15,954
    Market Cap (Jan-05-2024)
    0.291 Billion USD
    World Rank (Jul-30-2023)
    14,713
    Market Cap (Jul-30-2023)
    0.365 Billion USD
    World Rank (Dec-25-2022)
    13,575
    Market Cap (Dec-25-2022)
    0.420 Billion USD
    World Rank (Jan-07-2022)
    14,686
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Net Income in USD
    -24 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Axogen is a company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The headquarters is in USA.
    Facts About Company
    Axogen company annual revenue was 138 million USD and annual net loss was -28 million USD as on Dec-2022.
    Company Website
    AXOGEN

  2. Anika Therapeutics

    World Rank (Jan-05-2024)
    15,164
    Market Cap (Jan-05-2024)
    0.331 Billion USD
    World Rank (Jul-30-2023)
    14,877
    Market Cap (Jul-30-2023)
    0.355 Billion USD
    World Rank (Dec-25-2022)
    13,755
    Market Cap (Dec-25-2022)
    0.407 Billion USD
    World Rank (Jan-07-2022)
    13,435
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Revenue in USD
    147 Million USD
    Annual Net Income in USD
    4 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Anika offers a broad spectrum of therapeutic treatments ranging from osteoarthritis pain management to joint preservation and restoration. Its proprietary technology is based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body vital for proper joint health and tissue function.

    Company Website
    ANIKA THERAPEUTICS INC

  3. Emergent Biosolutions

    World Rank (Jan-05-2024)
    20,427
    Market Cap (Jan-05-2024)
    0.122 Billion USD
    World Rank (Jul-30-2023)
    15,101
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    11,808
    Market Cap (Dec-25-2022)
    0.549 Billion USD
    World Rank (Jan-07-2022)
    5,325
    Market Cap (Jan-07-2022)
    2.62 Billion USD
    Annual Revenue in USD
    1,792 Million USD
    Annual Net Income in USD
    230 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Emergent BioSolutions is a Biopharmaceutical company. The headquarters is in USA.
    Company Website
    EMERGENT BIOSOLUTIONS INC

  4. Vanda Pharmaceuticals

    World Rank (Jan-05-2024)
    16,835
    Market Cap (Jan-05-2024)
    0.246 Billion USD
    World Rank (Jul-30-2023)
    15,114
    Market Cap (Jul-30-2023)
    0.341 Billion USD
    World Rank (Dec-25-2022)
    14,050
    Market Cap (Dec-25-2022)
    0.389 Billion USD
    World Rank (Jan-07-2022)
    10,252
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    268 Million USD
    Annual Net Income in USD
    33 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Vanda Pharmaceuticals is a Biopharmaceutical company. The company expected annual revenue is 240 million USD to 260 million USD for 2020 and it has 270 employees as on 2020. The headquarters is in USA.
    Company Website
    VANDA PHARMACEUTICALS

  5. Pennant Group

    World Rank (Jan-05-2024)
    13,604
    Market Cap (Jan-05-2024)
    0.424 Billion USD
    World Rank (Jul-30-2023)
    15,211
    Market Cap (Jul-30-2023)
    0.336 Billion USD
    World Rank (Dec-25-2022)
    15,823
    Market Cap (Dec-25-2022)
    0.295 Billion USD
    World Rank (Jan-07-2022)
    12,828
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    439 Million USD
    Annual Net Income in USD
    2 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Pennant Group is a Home Health Care Services company. The company annual revenue in between 376 million USD to 386 million USD. The headquarters is in USA.
    Company Website
    PENNANT GROUP

  6. Aerie Pharmaceuticals

    World Rank (Jan-05-2024)
    15,308
    World Rank (Jul-30-2023)
    15,308
    World Rank (Dec-25-2022)
    15,308
    World Rank (Jan-07-2022)
    15,308
    Market Cap (Jan-07-2022)
    0.37 Billion USD
    Annual Revenue in USD
    83 Million USD
    Annual Net Income in USD
    -183 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Aerie Pharmaceuticals is a Ophthalmic Pharmaceuticals company. It focused on the discovery, development and commercialization of first in class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. The company annual revenue is 20.1 million USD and 353 employees as on 2020. The headquarters is in USA.
    Company Website
    AERIE PHARMACEUTICALS INC

  7. Cortexyme

    World Rank (Jan-05-2024)
    15,475
    World Rank (Jul-30-2023)
    15,475
    World Rank (Dec-25-2022)
    15,475
    World Rank (Jan-07-2022)
    15,475
    Market Cap (Jan-07-2022)
    0.36 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -77 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Cortexyme is a Clinical Stage Biopharmaceutical company. It is a pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed and other degenerative diseases. The company is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients that causes neurodegeneration and other pathology in animal models. The headquarters is in USA.
    Company Website
    CORTEXYME

  8. Bakhu Holdings

    World Rank (Jan-05-2024)
    27,253
    Market Cap (Jan-05-2024)
    0.030 Billion USD
    World Rank (Jul-30-2023)
    15,865
    Market Cap (Jul-30-2023)
    0.298 Billion USD
    World Rank (Dec-25-2022)
    15,689
    Market Cap (Dec-25-2022)
    0.301 Billion USD
    World Rank (Jan-07-2022)
    9,535
    Market Cap (Jan-07-2022)
    0.98 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ OTC
    Company Profile

    Bakhu Holdings holds a license to cell replication technology and related proprietary equipment, processes and formulations to produce, manufacture and sell cannabis related by-product sometimes referred in the industry as cannabinoids exclusively in North and Central America and the Caribbean. The headquarters is in USA.

    Company Website
    BAKHU HOLDINGS

  9. Stoke Therapeutics

    World Rank (Jan-05-2024)
    16,842
    Market Cap (Jan-05-2024)
    0.245 Billion USD
    World Rank (Jul-30-2023)
    16,233
    Market Cap (Jul-30-2023)
    0.280 Billion USD
    World Rank (Dec-25-2022)
    15,180
    Market Cap (Dec-25-2022)
    0.327 Billion USD
    World Rank (Jan-07-2022)
    11,113
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -85 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Stoke Therapeutics is a Biotechnology company. The company estimated annual revenue is currently 7.9 million USD per year and has 44 employees as on 2019. The headquarters is in USA.
    Company Website
    STOKE THERAPEUTICS

  10. Y-mAbs Therapeutics

    World Rank (Jan-05-2024)
    15,784
    Market Cap (Jan-05-2024)
    0.299 Billion USD
    World Rank (Jul-30-2023)
    16,389
    Market Cap (Jul-30-2023)
    0.273 Billion USD
    World Rank (Dec-25-2022)
    18,010
    Market Cap (Dec-25-2022)
    0.200 Billion USD
    World Rank (Jan-07-2022)
    12,185
    Market Cap (Jan-07-2022)
    0.61 Billion USD
    Annual Revenue in USD
    34 Million USD
    Annual Net Income in USD
    -55 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Y-mAbs Therapeutics is a Late Stage Clinical Biopharmaceutical company. It is focused on the development and commercialization of novel, antibody based therapeutic products for the treatment of cancer. The headquarters is in USA.
    Company Website
    Y-MABS THERAPEUTICS

Share